Article

ctDNA in Breast Milk for Early Detection of Pregnancy Associated Breast Cancer

2021-08-10

Abstract excerpt

<title>Abstract</title> <p>Pregnancy associated breast cancer (PABC) is an overall poor prognosis group compared to non-PABC breast cancer (BC), mainly due to late diagnosis. Effective screening approaches for early detection may improve its outcome. For the first time, we demonstrate the presence of cell-free tumor DNA (ctDNA) in the breast milk serum (sBM) of PABC in patients with early-stage disease and its ab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 86fceb5b-2937-5115-b1a1-3fcaeb2a9f48
DOI: 10.21203/rs.3.rs-757809/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ctDNA in Breast Milk for Early Detection of Pregnancy Associated Breast CancerDOI 10.21203/rs.3.rs-757809/v1Read

Early-Stage Breast Cancer Detection in Breast Milk.Semantic proximity Read

The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients.Semantic proximity Read

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision MedicineSemantic proximity Read

Clinical application of circulating tumor DNA in breast cancer.Semantic proximity Read

The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.Semantic proximity Read

Clinical applications of circulating tumor DNA in monitoring breast cancer drug resistance.Semantic proximity Read

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.Semantic proximity Read

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.Semantic proximity Read

Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.Semantic proximity Read

Development of a novel NGS methodology for ultrasensitive circulating tumour DNA detection as a tool for early-stage breast cancer diagnosisSemantic proximity Read

Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.Semantic proximity Read

The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.Semantic proximity Read